FORDYCE MARSHALL (President and CEO) received a stock award from VERA THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/20/2025ACC: 0001415889-25-004845
DirectorOfficer· President and CEO
Since May 2021
+242.25K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
242.25K acquired
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
+80.75K
Price / share
—
Trade value
—
% of position
56.2%
2/18/2025
143.60K→224.35K
Total
Net shares
+80.75K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 2/18/2025 | A · Award | +80.75K | — | — | 56.2% | 143.60K | 224.35K |
| Total | +80.75K | $0.00 | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Class A Common Stock
161.50K shares
Shares
+161.50K
Strike price
29.18
Held after
161.50K
Exercisable
—
2/18/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Class A Common Stock161.50K shares | 2/18/2025 | A · Award | +161.50K | 29.18 | — | 161.50K |
Non-Derivative Holdings (Post-Transaction)1
Class A Common Stock
IndirectShares owned222.03K
Total
222.03K indirect222.03K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Class A Common Stock | 222.03K | Indirect |
| Total | 222.03K | 222.03K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported